Based on the analysis of Helius Medical's profitability, liquidity, and operating efficiency, Helius Medical Technologies is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December. At this time, Helius Medical's Total Current Assets are comparatively stable compared to the past year. Other Liabilities is likely to gain to about 8.6 M in 2024, whereas Net Debt is likely to drop (5.4 M) in 2024. Key indicators impacting Helius Medical's financial strength include:
The financial analysis of Helius Medical is a critical element in measuring its lifeblood. Investors should not minimize Helius Medical's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income
(9.29 Million)
Helius
Select Account or Indicator
Market Cap
Enterprise Value
Price To Sales Ratio
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Research And Ddevelopement To Revenue
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Price Fair Value
Return On Equity
Change In Cash
Stock Based Compensation
Free Cash Flow
Change In Working Capital
Other Cashflows From Financing Activities
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Sale Purchase Of Stock
Investments
Net Borrowings
Begin Period Cash Flow
Total Cashflows From Investing Activities
Depreciation
Change To Account Receivables
Change To Operating Activities
Change To Netincome
Change To Liabilities
Change To Inventory
Change Receivables
Exchange Rate Changes
Cash And Cash Equivalents Changes
Cash Flows Other Operating
Other Cashflows From Investing Activities
Issuance Of Capital Stock
Common Stock Shares Outstanding
Total Assets
Total Current Liabilities
Total Stockholder Equity
Net Tangible Assets
Net Debt
Retained Earnings
Accounts Payable
Cash
Cash And Short Term Investments
Common Stock Total Equity
Liabilities And Stockholders Equity
Other Current Assets
Total Liab
Short Long Term Debt
Total Current Assets
Short Term Debt
Common Stock
Other Current Liab
Other Liab
Net Receivables
Retained Earnings Total Equity
Non Current Liabilities Total
Capital Surpluse
Other Stockholder Equity
Accumulated Other Comprehensive Income
Non Current Assets Total
Non Currrent Assets Other
Property Plant And Equipment Net
Current Deferred Revenue
Net Invested Capital
Property Plant And Equipment Gross
Net Working Capital
Property Plant Equipment
Inventory
Capital Stock
Short Long Term Debt Total
Capital Lease Obligations
Intangible Assets
Interest Expense
Selling General Administrative
Other Operating Expenses
Operating Income
Ebit
Research Development
Ebitda
Total Operating Expenses
Income Before Tax
Income Tax Expense
Total Revenue
Gross Profit
Net Income From Continuing Ops
Cost Of Revenue
Total Other Income Expense Net
Net Income Applicable To Common Shares
Depreciation And Amortization
Non Operating Income Net Other
Net Interest Income
Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
Understanding current and past Helius Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Helius Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Helius Medical's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Helius Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Helius Medical Technologies. Check Helius Medical's Beneish M Score to see the likelihood of Helius Medical's management manipulating its earnings.
Helius Medical Stock Summary
Helius Medical competes with Nuwellis, ReShape Lifesciences, Bone Biologics, SINTX Technologies, and Tivic Health. Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator , is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. Helius Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 19 people.
The reason investors look at the income statement is to determine what Helius Medical's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Helius Medical's current stock value. Our valuation model uses many indicators to compare Helius Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Helius Medical competition to find correlations between indicators driving Helius Medical's intrinsic value. More Info.
Helius Medical Technologies is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Helius Medical's Return On Equity is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Helius Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Helius Medical Techn Systematic Risk
Helius Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Helius Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Helius Medical Techn correlated with the market. If Beta is less than 0 Helius Medical generally moves in the opposite direction as compared to the market. If Helius Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Helius Medical Techn is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Helius Medical is generally in the same direction as the market. If Beta > 1 Helius Medical moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Helius Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Helius Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Helius Medical growth as a starting point in their analysis.
Helius Medical November 23, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Helius Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Helius Medical Technologies. We use our internally-developed statistical techniques to arrive at the intrinsic value of Helius Medical Technologies based on widely used predictive technical indicators. In general, we focus on analyzing Helius Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Helius Medical's daily price indicators and compare them against related drivers.
When running Helius Medical's price analysis, check to measure Helius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Helius Medical is operating at the current time. Most of Helius Medical's value examination focuses on studying past and present price action to predict the probability of Helius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Helius Medical's price. Additionally, you may evaluate how the addition of Helius Medical to your portfolios can decrease your overall portfolio volatility.